多内分泌代谢性卵巢综合征女性的健康社会决定因素与心血管疾病
进一步调整SDoH后,亚洲和西班牙裔女性的差异仍显著,而黑人女性的差异不再显著。
要点
- PMOS女性ASCVD风险存在种族差异。
- 调整合并症后,黑人及西班牙裔女性风险高于白人。
- 控制SDoH后黑人女性风险差异不再显著。
核心结论
- PMOS女性中ASCVD风险存在种族差异,部分差异由健康社会决定因素解释。
主要发现
- 调整医疗合并症后(模型2),黑人女性(aHR 1.10;95%CI 1.02-1.19)和西班牙裔女性(aHR 1.21;95%CI 1.12-1.29)ASCVD风险高于白人女性。
- 进一步调整SDoH后(模型3),亚洲和西班牙裔女性的风险差异仍显著,黑人女性的差异不再显著。
- 控制SDoH后,黑人女性多个ASCVD组分的高风险不再显著。
临床怎么用
- 临床评估PMOS女性ASCVD风险时应考虑种族/族裔差异。
- 关注健康社会决定因素(如住房所有权、净资产、教育)对ASCVD风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: No studies have explored racial differences in atherosclerotic cardiovascular disease (ASCVD) in women with polycystic ovary syndrome (PCOS), which is now known as polyendocrine metabolic ovarian syndrome (PMOS). OBJECTIVE: Compare ASCVD risk by race/ethnicity among women with PMOS and determine whether social determinants of health (SDoH) drive associations. DESIGN: Cohort study. SETTING: Optum's de-identified Clinformatics® Data Mart Database (2000-2022). PARTICIPANTS: Women aged 18 to 50 with PMOS using PCOS International Classification of Diseases 9/10 codes. Race/ethnicity was categorized as White, Black, Asian, or Hispanic. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Primary outcome was risk of composite ASCVD (coronary artery disease, cerebrovascular disease, peripheral artery disease). Secondary outcomes included each component. Adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models that were unadjusted (Model 1), adjusted for medical comorbidities (Model 2), and adjusted for comorbidities plus SDoH: homeownership, net worth, and education (Model 3). RESULTS: The sample included 413 450 women with PMOS. Accounting for medical comorbidities (Model 2), Asian women with PMOS were at a lower risk for ASCVD compared with White women (aHR, .65; 95% CI, .56-.74), and Black (aHR, 1.10; 95% CI, 1.02-1.19) and Hispanic women (aHR, 1.21; 95% CI, 1.12-1.29) were at a higher risk. After adjusting for SDoH (Model 3), the findings for Asian and Hispanic women remained significant, whereas those for Black women did not. When looking at individual components of ASCVD, the higher risk for multiple components among Black women was no longer significant after controlling for SDoH. CONCLUSION: Racial differences exist in risk of ASCVD among women with PMOS.
引用
- Alur-Gupta S, DiTosto JD, Busse KR, et al. Social determinants of health and cardiovascular disease in women with polyendocrine metabolic ovarian syndrome (PCOS/PMOS). J Clin Endocrinol Metab. 2026. PMID: 42530028. doi:10.1210/clinem/dgag308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。